Review for Analytical Methods for the Determination of Sodium Cephalothin

Formulation and characterization of antibiotic drug loaded aquasome for the topical application

Aim: This study aimed to develop a topical antibiotic drug delivery system using aquasomes for enhanced treatment of skin and soft tissue infections (SSTIs). Materials & methods: Cephalothin was loaded into aquasomes using a multi-step process and optimized using design of experiment. The aquasomes were characterized for FT-IR, SEM and zeta potential analysis. Entrapment efficacy, In vitro drug release studies, antibacterial assays and stability study was performed to evaluate the efficacy of the formulated aquasomes. Results & conclusion: The formulated cephalothin-loaded aquasomes exhibited stable properties, controlled drug release and significant antibacterial activity against bacteria. This proves that the developed aquasome-based delivery system has the potential for sustained treatment of SSTIs.

Little-Cost Potentiometric and Spectrophotometric Procedures for Cephalothin Assessment in Pure and Biological Fluids

Low-cost potentiometric and spectrophotometric procedures for cephalothin (CPI) determination in pure and biological fluids were investigated. The potentiometric technique is created through titration of CPI with an aqueous medium of 0.1 M NaOH at an ionic strength of μ = 0.3 M sodium chloride and room temperature by a combined glass pH electrode. Using the standard addition method, we found that the detection and quantitative limits were 0.042 mg/mL, with the standard deviation SD = 0.011, correlation coefficient R = 0.9880 (n = 5), and linear concentration ranges from 0.042 to 0.82 mg/mL. This technique was utilized to assess CPI in pure solutions, urine, and serum with suitable results. No interference was exposed in the presence of public components of the samples under study. Recovery of CPI for pure and biological fluids is in the range of 98.2-101%. Also, the spectrophotometric method has been performed through the formation of the Prussian Blue (PB) complex. The reaction between the acidic hydrolysis product of CPI (T = 60 °C) and the mixture of Fe3+ with hexacyanoferrate (III) ions (HCF(III)) was detected for the spectrophotometric determination of the drug. The maximum absorbance of the formed complex was measured at λ = 283 nm with 2.0 × 103 L mol-1 cm-1 molar absorptivity. Reaction states have been advanced to acquire the PB complex of great sensitivity and longer stability. In optimal states, the absorbent of the PB compound was attained to grow linearly with the increase in the concentration of CPI, which agrees with the correlation coefficient values. The detection and quantitative limits were 0.000036 and 0.0012 mg/mL, respectively, with the standard deviation, SD = 0.0005, correlation coefficient, R = 0.9955 (n = 5), and the linearity range of the calibration plot 0.0005-0.02 mg/mL CPI. The planned technique was positively utilized for the detection of CPI in both urine and serum models. The results fit well with the data found from the potentiometric method.

Oral Staphylococcus Species and MRSA Strains in Patients with Orofacial Clefts Undergoing Surgical Rehabilitation Diagnosed by MALDI-TOF MS

This study investigated the occurrence and dynamics of oral Staphylococcus species in patients with orofacial clefts undergoing surgical rehabilitation treatment. Patients (n = 59) were statistically stratified and analyzed (age, gender, types of orofacial clefts, surgical history, and types of previous surgical rehabilitation). Salivary samples were obtained between hospitalization and the return to the specialized medical center. Microbiological diagnosis was performed by classical methods, and MALDI-TOF MS. MRSA strains (SCCmec type II, III, and IV) were characterized by the Decision Tree method. A total of 33 (55.9%) patients showed oral staphylococcal colonization in one, two, or three sampling steps. A high prevalence has been reported for S. aureus (including HA-, MRSA and CA-MRSA), followed by S. saprophyticus, S. epidermidis, S. sciuri, S. haemolyticus, S. lentus, S. arlettae, and S. warneri. The dynamics of oral colonization throughout surgical treatment and medical follow-up may be influenced by (i) imbalances in staphylococcal maintenance, (ii) efficiency of surgical asepsis or break of the aseptic chain, (iii) staphylococcal neocolonization in newly rehabilitated anatomical oral sites, and (iv) total or partial maintenance of staphylococcal species. The highly frequent clinical periodicity in specialized medical and dental centers may contribute to the acquisition of MRSA in these patients.

HPLC methods for choloroquine determination in biological samples and pharmaceutical products

OBJECTIVE

Review and assess pharmaceutical and clinical characteristics of chloroquine including high-performance liquid chromatography (HPLC)-based methods used to quantify the drug in pharmaceutical products and biological samples.

EVIDENCE ACQUISITION

A literature review was undertaken on the PubMed, Science Direct, and Scielo databases using the following keywords related to the investigated subject: 'chloroquine', 'analytical methods', and 'HPLC'.

RESULTS

For more than seven decades, chloroquine has been used to treat malaria and some autoimmune diseases, such as lupus erythematosus and rheumatoid arthritis. There is growing interest in chloroquine as a therapeutic alternative in the treatment of HIV, Q fever, Whipple's disease, fungal, Zika, Chikungunya infections, Sjogren's syndrome, porphyria, chronic ulcerative stomatitis, polymorphic light eruption, and different types of cancer. HPLC coupled to UV detectors is the most employed method to quantify chloroquine in pharmaceutical products and biological samples. The main chromatographic conditions used to identify and quantify chloroquine from tablets and injections, degradation products, and metabolites are presented and discussed.

CONCLUSION

Research findings reported in this article may facilitate the repositioning, quality control, and biological monitoring of chloroquine in modern pharmaceutical dosage forms and treatments.